Recent Quotes (30 days)

You have no recent quotes
chg | %

Covalon Technologies Ltd  

(Public, CVE:COV)   Watch this stock  
Find more results for COV
0.00 (0.00%)
Delayed:   10:00AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.18 - 1.19
52 week 0.57 - 1.27
Open 1.18
Vol / Avg. 5,800.00/17,990.00
Mkt cap 10.98M
P/E     -
Div/yield     -
EPS -0.04
Shares 9.31M
Beta -0.68
Inst. own     -
May 31, 2016
Q2 2016 Covalon Technologies Ltd Earnings Call - 9:00AM EDT - Add to calendar
Mar 2, 2016
Q1 2016 Covalon Technologies Ltd Earnings Call
Feb 29, 2016
Q1 2016 Covalon Technologies Ltd Earnings Release

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 10.95% -12.41%
Operating margin 13.18% -9.99%
EBITD margin - -6.81%
Return on average assets 13.16% -12.08%
Return on average equity 21.70% -18.27%
CDP Score - -


Suite 106, 405 Britannia Road East
+1-905-5688400 (Phone)
+1-905-5685200 (Fax)

Website links


Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care and infection management. Its products include ColActive and ColActive Plus, which are collagen matrix dressings; IV Clear and SurgiClear, which is a line of antimicrobial clear silicone adhesive dressings with chlorhexidine and silver, and SilverCoat, which is a line of antimicrobial silicone foley catheters. The Company’s products are marketed to various health care providers, such as hospitals, wound care centers, burn centers and acute care facilities. Its technologies are used to prevent, detect and manage medical conditions, such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. It sells under Covalon’s name. The Company has three platform technologies for medical devices: Collagen matrix, Antimicrobial silicone adhesive and Medical coating technology.

Officers and directors

Abe Schwartz Chairman of the Board
Brian E. Pedlar President, Chief Executive Officer, Director
Danny Brannagan Chief Financial Officer
Valerio DiTizio Chief Scientific Officer
Kim Crooks Vice President - Operations
John Hands Senior Director - Global Marketing
Elinor Caplan Director
Martin C. Bernholtz Independent Director
Ian Brindle Independent Director
Joseph Cordiano Independent Director